Agenda Archive

  • Research collaboration between EraCal Therapeutics and Nestlé Health Science

    More …

  • CSS and EPFL Innovation Park announced last week the innovation projects that have been selected in their Future of Health (FoHG) program. 

    More …

  • Two new UZH spin-offs join ESA BIC Switzerland, the Swiss Space Incubator 

    More …

  • Prometheus AG wins the Orbital Reef Starter Innovation Challenge.

    More …

  • SingMax is the winner of the Digital Entrepreneurship Bootcamp 2022 edition. 

    More …

  • PayMate is the winner team  of the UZH Innovathon: Building a human-centered Future of Work.

    More …

  • Former  UZH MedTech Entrepreneur fellow David Gage and aiEndoscopic won  the Swiss Innovation Challenge 2022.

    More …

  • UZH Entrepreneur Fellow Merens Derungs and his startup Arcton were among the illustrious circle of 6 startups that were allowed to present themselves at the Startup Nights in Winterthur.  

    More …

  • The UZH spin-off Navignostics raises CHF 7.5M in a seed financing round to advance precision cancer medicine through spatial single-cell proteomics.

    More …

  • Former MedTech UZH Entrepreneur fellow Dr. Deana Mohr  and her company Muvon Therapeutics announce first patient enrolled in phase II clinical study.

    More …

  • Im UZH Innovation Office übernimmst Du administrative und operative Aufgaben zur Unterstützung der verschiedener Aktivitäten im UZH Innovation Hub. Es wartet eine vielseitige und verantwortungsvolle Einstiegsposition in einem dynamischen Umfeld auf Dich.

    More …

  • Former MedTech UZH Entrepreneur fellow Dr. Prajwal and his company Clemedi release Tuberculini, a molecular test for drug-resistant tuberculosis.

    More …

  • Molecular biologist and former UZH Entrepreneur Fellow Ana Montalban-Arques has made a discovery that could cure colon cancer.

    More …

  • "Engineer the future as an entrepreneur? Why not?" - that was the theme of this year's Credit Suisse Entrepreneurs' Conference. The inspiring panel discussions and keynote speeches also featured entrepreneurial researchers from the University of Zurich.

    More …

  • The UZH Innovation Hub is partnering with Talent Kick, a program where students have the opportunity to form interdisciplinary cross-university co-founder teams and benefit from hands-on entrepreneurial experience during studies.

    More …

  • The University of Zurich with Dr. Sarah Ebling in the lead, has been granted funding for a large innovation project to break communication barriers for better social inclusion. The Swiss Innovation Agency (Innosuisse) has granted CHF 12.4 Mio for this four-year flagship project entitled “Inclusive Information and Communication Technologies” (IICT).

    More …

  • The active ingredient aducanumab, which was discovered at the University of Zurich, has been approved for use in the United States as a treatment for Alzheimer’s disease. Aducanumab, a human antibody, is the first treatment to slow down incurable Alzheimer's disease. 

    More …

  • In a facilitated five day innovation sprint students and researchers from three universities will work together to develop, prototype and test new ideas with a  focus on sustainability and impact based on the SDGs.

    More …

  • The majority of the spin-offs founded at the UZH are active in the fields of biotech and medicine. At the UZH Innovation Hub we support research projects in four innovation areas, including biotech and life sciences. 

    More …

  • Molecular Partners announced their collaboration with Novartis on potential medicines for use against COVID-19. Molecular Partners will be responsible for Phase 1 and 2 trials for its two therapeutic candidates. If the trials are successful, Novartis will be responsible for further development, manufacturing, and global commercialization.

    More …

You can find all of the latests news and events related to innovation and entrepreneurship at the University of Zurich here.

Read further for information about the latest technologies and licensing opportunities for industry and business partners.